Evidence map›Paper›PMID 30170124›Full record

ArticleThe Journal of allergy and clinical immunology2019

Allergen content in German cockroach extracts and sensitization profiles to a new expanded set of cockroach allergens determine in vitro extract potency for IgE reactivity.

Jill Glesner, Stephanie Filep, Lisa D Vailes, Sabina Wünschmann, Martin D Chapman, Giovanni Birrueta, April Frazier, Kyoung Yong Jeong, Coby Schal, Leonard Bacharier and 5 more

Open access · greenAbstract read
In one paragraph

Article in The Journal of allergy and clinical immunology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed
3.9field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 54 citations in OpenAlex.

  1. Trial
  2. Trial
  3. The association of allergic sensitization patterns in early childhood with disease manifestations and immunological reactivity at 10 years of age.Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology · 2019
    Trial
  4. Reclassification of GST Allergens Based on Their Cross-Reactivity in Two Divergent Cockroach Species.Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology · 2026
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Effective delivery of miR-511-3p with mannose-decorated exosomes with RNA nanoparticles confers protection against asthma.Journal of controlled release : official journal of the Controlled Release Society · 2024
    Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Review
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

15 authors at 7 institutions in 2 countries.

Jill GlesnerIndoor Biotechnologies, Charlottesville, Va.
Stephanie FilepIndoor Biotechnologies, Charlottesville, Va.
Lisa D VailesIndoor Biotechnologies, Charlottesville, Va.
Sabina WünschmannIndoor Biotechnologies, Charlottesville, Va.
Martin D ChapmanIndoor Biotechnologies, Charlottesville, Va.
Giovanni BirruetaLa Jolla Institute for Allergy & Immunology, La Jolla, Calif.
April FrazierLa Jolla Institute for Allergy & Immunology, La Jolla, Calif.
Kyoung Yong JeongDepartment of Internal Medicine, Institute of Allergy, Yonsei University College of Medicine, Seoul, Korea.
Coby SchalDepartment of Entomology and Plant Pathology, North Carolina State University, Raleigh, NC.
Leonard BacharierDepartment of Pediatrics, Washington University School of Medicine, St Louis, Mo.
Avraham BeigelmanDepartment of Pediatrics, Washington University School of Medicine, St Louis, Mo.
Paula BusseDivision of Clinical Immunology, Icahn School of Medicine at Mount Sinai, New York, NY.
Véronique SchultenLa Jolla Institute for Allergy & Immunology, La Jolla, Calif.
Alessandro SetteLa Jolla Institute for Allergy & Immunology, La Jolla, Calif; Department of Medicine, University of California San Diego, La Jolla, Calif.
Anna PomésIndoor Biotechnologies, Charlottesville, Va. Electronic address: apomes@inbio.com.
Indoor Biotechnologies (United States) · USLa Jolla Institute for Immunology · USWashington University in St. Louis · USIcahn School of Medicine at Mount Sinai · USNorth Carolina State University · USUniversity of California, San Diego · USYonsei University · KR

Funding

Inner City Asthma consortium 3 (ICAC3)UM1AI114271 · NIAID · UNIVERSITY OF WISCONSIN-MADISON · PI GERN, JAMES E., JACKSON, DANIEL J · 2014 to 2021
$79.4M
Antigenic determinants of asthma-associated allergens for design of immunotherapy.R01AI077653 · NIAID · INDOOR BIOTECHNOLOGIES · PI MARTIN D. CHAPMAN, Maksymilian Chruszcz · 2009 to 2026
$9.5M
Understanding mechanisms in specific immunotherapy (SIT)U19AI100275 · NIAID · LA JOLLA INSTITUTE FOR IMMUNOLOGY · PI SETTE, ALESSANDRO · 2012 to 2017
$8.1M
Towards the identification of biomarkers for pediatric milk allergyU19AI135731 · NIAID · LA JOLLA INSTITUTE FOR IMMUNOLOGY · PI VIJAYANAND, PANDURANGAN · 2018 to 2022
$5.6M
NIAID NIH HHS R01 AI077653NIAID NIH HHS U19 AI100275NIAID NIH HHS U19 AI135731NIAID NIH HHS UM1 AI114271
6 · The paper itself

Abstract

backgroundCockroach allergens are an important cause of IgE-mediated sensitization in inner-city asthmatic patients. However, cockroach extracts used for diagnosis and immunotherapy are not standardized.

objectiveWe sought to determine the allergen content of nonstandardized German cockroach extracts and the levels of sensitization to an expanded set of cockroach allergens as determinants of in vitro extract potency for IgE reactivity.

methodsTwelve German cockroach extracts were compared for allergen content and potency of IgE reactivity. Bla g 1, Bla g 2, and Bla g 5 were measured by using immunoassays. IgE antibody levels to 8 purified recombinant allergens from groups 1, 2, 4, 5, 6, 7, 9, and 11 were measured by using ImmunoCAP. IgE antibody binding inhibition assays were performed to assess extract in vitro potencies (concentration inhibiting 30% of the total IgE antibody-binding inhibition) relative to an arbitrarily selected reference extract in 5 patients with cockroach allergy.

resultsAllergen levels were highly variable. Three new major allergens (groups 6, 9, and 11), were identified among highly cockroach-sensitized subjects (CAP class ≥ 3). Sensitization profiles were unique per subject without immunodominant allergens. The sum of IgE to 8 allergen components showed a good correlation with cockroach-specific IgE levels (r = 0.88, P < .001). In vitro potencies varied among different extracts per subject and among subjects for each extract.

conclusionsThe in vitro potency of German cockroach extracts for IgE reactivity depends on allergen content and allergen-specific IgE titers of patients with cockroach allergy. These factors are relevant for selection of potent extracts to be used for immunotherapy and for the design and interpretation of data from immunotherapy trials.

Indexed as

AllergensAnimalsBlattellidaeFemaleHumansHypersensitivityImmunoglobulin EInsect ProteinsMaleAllergensImmunoglobulin EInsect Proteinscockroach allergen componentsCockroach allergydiagnosisimmunotherapynon-standardized extracts

Identifiers

PMID30170124
PMCPMC6395535
OpenAlexW2889056640

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.